Literature DB >> 2379159

Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor.

T Himeno1, N Watanabe, N Yamauchi, M Maeda, Y Tsuji, T Okamoto, H Neda, Y Niitsu.   

Abstract

Based on the finding that expression of endogenous tumor necrosis factor (TNF) which is not detected in TNF-susceptible cells was observed in TNF-resistant cells, the assumption was made that endogenous TNF may be a protective protein against the cytotoxic activity of TNF. In order to confirm this possibility, we investigated the relationship between expression of endogenous TNF and TNF susceptibility by using the gene transfection method. When L-M, TNF-highly sensitive murine fibrosarcoma cells were transfected with a human TNF gene, the stable transfectants expressed endogenous TNF and acquired resistance to TNF. Conversely, when endogenous TNF synthesis was inhibited by introducing an antisense TNF gene into HeLa, TNF-less sensitive human cervical cancer cells, the sensitivity was enhanced. These findings indicate that endogenous TNF is one of the protective factors against the cytotoxic activity of TNF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379159

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Cellular targets of exogenous tumour necrosis factor-alpha (TNF alpha) in human gliomas.

Authors:  M Maruno; T Yoshimine; T Isaka; A Ghulam Muhammad; K Nishioka; T Hayakawa
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cells.

Authors:  B Gonen; O Kahana; I P Witz
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Effects of tumor necrosis factor alpha, interferon alpha and interferon gamma on non-lymphoid leukemia cell lines: growth inhibition, differentiation induction and drug sensitivity modulation.

Authors:  A Kikuchi; V Holán; J Minowada
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production.

Authors:  Y Itoh; Y Koshita; M Takahashi; N Watanabe; Y Kohgo; Y Niitsu
Journal:  Cancer Immunol Immunother       Date:  1995-02       Impact factor: 6.968

5.  Anti-tumor pharmacological evaluation of extracts from stellera chamaejasme L based on hollow fiber assay.

Authors:  Xiaoni Liu; Qing Yang; Ganlin Zhang; Yujie Li; Ying Chen; Xiaogang Weng; Yajie Wang; Yiwei Wang; Xiaoxin Zhu
Journal:  BMC Complement Altern Med       Date:  2014-03-31       Impact factor: 3.659

6.  Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.

Authors:  N Watanabe; N Yamauchi; H Neda; M Maeda; Y Tsuji; T Okamoto; S Akiyama; H Sasaki; N Tsuji; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1992-06

7.  Synergistic suppressive effect of double transfection of tumor necrosis factor-alpha and interleukin 12 genes on tumorigenicity of Meth-A cells.

Authors:  H Fujiwara; N Yamauchi; Y Sato; K Sasaki; M Takahashi; T Okamoto; T Sato; S Iyama; Y Koshita; M Hirayama; H Yamagishi; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  2000-12

8.  Reversal of tumor necrosis factor resistance in tumor cells by adriamycin via suppression of intracellular resistance factors.

Authors:  N Watanabe; T Okamoto; N Tsuji; H Sasaki; S Akiyama; D Kobayashi; T Sato; N Yamauchi; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1995-04

9.  Induction of synthesis of heat shock protein 72 in tumor necrosis factor gene-transduced cells.

Authors:  N Watanabe; S Akiyama; N Tsuji; H Sasaki; N Yamauchi; T Okamoto; D Kobayashi; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1994-10

10.  Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice.

Authors:  M Maeda; N Watanabe; N Tsuji; Y Tsuji; T Okamoto; H Sasaki; S Akiyama; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1993-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.